Relationship between epigenetic and metabolic alterations in castration-resistant prostate cancer

被引:0
|
作者
Kanesaka, Manato [1 ,2 ]
Sato, Hiroaki [2 ]
Hoshii, Takayuki [1 ]
Okabe, Atsushi [1 ]
Fukuyo, Masaki [1 ]
Nawai, Bahityar R. [1 ]
Sakamoto, Shinichi [2 ]
Komiya, Akira [2 ]
Ichikawa, Tomohiko [2 ]
Kaneda, Atsushi [1 ]
机构
[1] Chiba Univ, Grad Sch Med, Dept Mol Oncol, Chiba, Japan
[2] Chiba Univ, Grad Sch Med, Dept Urol, Chiba, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P14-31-3
引用
收藏
页码:1592 / 1592
页数:1
相关论文
共 50 条
  • [1] Somatic Alterations Contributing to Metastasis of a Castration-Resistant Prostate Cancer
    Nickerson, Michael L.
    Im, Kate M.
    Misner, Kevin J.
    Tan, Wei
    Lou, Hong
    Gold, Bert
    Wells, David W.
    Bravo, Hector C.
    Fredrikson, Karin M.
    Harkins, Timothy T.
    Milos, Patrice
    Zbar, Berton
    Linehan, W. Marston
    Yeager, Meredith
    Andresson, Thorkell
    Dean, Michael
    Bova, G. Steven
    HUMAN MUTATION, 2013, 34 (09) : 1231 - 1241
  • [2] Relationship between Circulating Lipids and Cytokines in Metastatic Castration-Resistant Prostate Cancer
    Lin, Hui-Ming
    Yeung, Nicole
    Hastings, Jordan F.
    Croucher, David R.
    Huynh, Kevin
    Meikle, Thomas G.
    Mellett, Natalie A.
    Kwan, Edmond M.
    Davis, Ian D.
    Tran, Ben
    Mahon, Kate L.
    Zhang, Alison
    Stockler, Martin R.
    Briscoe, Karen
    Marx, Gavin
    Bastick, Patricia
    Crumbaker, Megan L.
    Joshua, Anthony M.
    Azad, Arun A.
    Meikle, Peter J.
    Horvath, Lisa G.
    CANCERS, 2021, 13 (19)
  • [3] DIETHYLSTILBESTROL IN CASTRATION-RESISTANT PROSTATE CANCER OESTROGENS IN CASTRATION-RESISTANT PROSTATE CANCER: BACK TO THE FUTURE?
    Sartor, Oliver
    BJU INTERNATIONAL, 2012, 110 (11B) : E736 - E736
  • [4] A novel epigenetic driver and actionable target in castration-resistant prostate cancer
    Cacciatore, A.
    Sandrini, G.
    Musumeci, C.
    Guarrera, L.
    Albino, D.
    Bolis, M.
    Catapano, C., V
    Carbone, G. M.
    EUROPEAN UROLOGY, 2023, 83
  • [5] Common Structural and Epigenetic Changes in the Genome of Castration-Resistant Prostate Cancer
    Friedlander, Terence W.
    Roy, Ritu
    Tomlins, Scott A.
    Ngo, Vy T.
    Kobayashi, Yasuko
    Azameera, Aruna
    Rubin, Mark A.
    Pienta, Kenneth J.
    Chinnaiyan, Arul
    Ittmann, Michael M.
    Ryan, Charles J.
    Paris, Pamela L.
    CANCER RESEARCH, 2012, 72 (03) : 616 - 625
  • [6] The Relationship between Sarcopenia and Survival after Cabazitaxel Treatment for Castration-Resistant Prostate Cancer
    Onishi K.
    Tanaka N.
    Hori S.
    Nakai Y.
    Miyake M.
    Anai S.
    Fujimoto K.
    Tribologie und Schmierungstechnik, 2022, 69 (04): : 217 - 225
  • [7] Darolutamide For Castration-Resistant Prostate Cancer
    Bastos, Diogo A.
    Antonarakis, Emmanuel S.
    ONCOTARGETS AND THERAPY, 2019, 12 : 8769 - 8777
  • [8] miRNA alterations associated with transition of advanced castration-resistant prostate cancer to neuroendocrine prostate cancer
    Bhagirath, Divya
    Yang, Thao
    Tabatabai, Laura
    Majid, Shahana
    Dahiya, Rajvir
    Tanaka, Yuichiro
    Saini, Sharanjot
    CANCER RESEARCH, 2019, 79 (13)
  • [9] Immunotherapy for Castration-Resistant Prostate Cancer
    Sonpavde, Guru
    Kantoff, Philip W.
    UROLOGIC CLINICS OF NORTH AMERICA, 2012, 39 (04) : 465 - +
  • [10] Metastatic castration-resistant prostate cancer
    Henriques, Vanessa
    Wenzel, Mike
    Demes, Melanie-Christin
    Koellermann, Jens
    PATHOLOGE, 2021, 42 (04): : 431 - 438